Sumarago, Bb Boy .
HRN: 21-39-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/22/2022
06/29/2022
IV
14 Mg
Q8
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes